Genmab reported 532M in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Amarin AMRN:US -1331000 8.49M
Amgen AMGN:US $ 2129M 121M
AstraZeneca AZN:LN 1.4B 366M
Bayer BAYN:GR 3.07B 885M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bluebird Bio BLUE:US $ -230839000 25.98M
Fresenius Medical Care FME:GR 446M 29.08M
Galapagos GLPG:NA -50798000 35.32M
Genmab GEN:DC 532M 355M
GlaxoSmithKline GSK:LN 1.96B 281M
GN Store Nord GN:DC 712M 17M
GRIFOLS GRF:SM 204.34M 44.09M
H. Lundbeck A/S LUN:DC 882M 662M
Hikma Pharmaceutical HIK:LN 278M 16M
Immunogen IMGN:US $ -27369000 1.55M
Insmed INSM:US $ -83833000 10.7M
Lonza Group LONN:SW 599M 271M
Novartis NOVN:VX 2.99B 332M
Regeneron Pharmaceuticals REGN:US $ 1112.7M 54.3M
Seattle Genetics SGEN:US $ -89603000 32.82M
William Demant Holding WDH:DC 1.47B 1.67B